228 related articles for article (PubMed ID: 10477577)
1. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.
Kyburz D; Corr M; Brinson DC; Von Damm A; Tighe H; Carson DA
J Immunol; 1999 Sep; 163(6):3116-22. PubMed ID: 10477577
[TBL] [Abstract][Full Text] [Related]
2. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
Bishop GA; Warren WD; Berton MT
Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
Macaulay AE; DeKruyff RH; Goodnow CC; Umetsu DT
J Immunol; 1997 May; 158(9):4171-9. PubMed ID: 9126977
[TBL] [Abstract][Full Text] [Related]
4. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.
Lederman S; Yellin MJ; Cleary AM; Pernis A; Inghirami G; Cohn LE; Covey LR; Lee JJ; Rothman P; Chess L
J Immunol; 1994 Mar; 152(5):2163-71. PubMed ID: 7907632
[TBL] [Abstract][Full Text] [Related]
5. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival.
Yin D; Zhang L; Wang R; Radvanyi L; Haudenschild C; Fang Q; Kehry MR; Shi Y
J Immunol; 1999 Oct; 163(8):4328-34. PubMed ID: 10510372
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
Jaiswal AI; Croft M
J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand exerts differential effects on the expression of I gamma transcripts in subclones of an IgM+ human B cell lymphoma line.
Ford GS; Yin CH; Barnhart B; Sztam K; Covey LR
J Immunol; 1998 Jan; 160(2):595-605. PubMed ID: 9551893
[TBL] [Abstract][Full Text] [Related]
8. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.
Johnson-Léger C; Christenson JR; Holman M; Klaus GG
J Immunol; 1998 Nov; 161(9):4618-26. PubMed ID: 9794390
[TBL] [Abstract][Full Text] [Related]
11. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
[TBL] [Abstract][Full Text] [Related]
13. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40.
Tsubata T; Wu J; Honjo T
Nature; 1993 Aug; 364(6438):645-8. PubMed ID: 7688865
[TBL] [Abstract][Full Text] [Related]
14. Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a.
Hasbold J; Hong JS; Kehry MR; Hodgkin PD
J Immunol; 1999 Oct; 163(8):4175-81. PubMed ID: 10510353
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
16. Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships.
Sharma MD; Leite de Moraes M; Zavala F; Pontoux C; Papiernik M
J Immunol; 1998 Nov; 161(10):5357-65. PubMed ID: 9820509
[TBL] [Abstract][Full Text] [Related]
17. Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens.
Gordon J; Katira A; Holder M; MacDonald I; Pound J
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():1-13. PubMed ID: 7524882
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of rheumatoid factors by superantigens and human helper T cells.
He XW; Goronzy J; Weyand C
J Clin Invest; 1992 Feb; 89(2):673-80. PubMed ID: 1371126
[TBL] [Abstract][Full Text] [Related]
19. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factor B cell tolerance via autonomous Fas/FasL-independent apoptosis.
Warnatz K; Kyburz D; Brinson DC; Lee DJ; Von Damm A; Engelhart M; Corr M; Carson DA; Tighe H
Cell Immunol; 1999 Jan; 191(1):69-73. PubMed ID: 9918688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
